{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:59:04Z","timestamp":1775321944917,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001634"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001634"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","award":["CZ.2.16\/3.1.00\/24022"],"award-info":[{"award-number":["CZ.2.16\/3.1.00\/24022"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00043"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00043"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","award":["IP00064203"],"award-info":[{"award-number":["IP00064203"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","award":["LM2015091"],"award-info":[{"award-number":["LM2015091"]}],"id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006136","name":"Fuel Cell Technologies Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012329","name":"Ministry of Sports and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001457","name":"Media Development Authority - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["AMARAL16I0"],"award-info":[{"award-number":["AMARAL16I0"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["K109076"],"award-info":[{"award-number":["K109076"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["UID\/MULTI\/04046\/2013"],"award-info":[{"award-number":["UID\/MULTI\/04046\/2013"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jcf.2018.08.013","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T04:48:47Z","timestamp":1538023727000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment"],"prefix":"10.1016","volume":"18","author":[{"suffix":"Jr","given":"B\u00e9la","family":"Nagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Bene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Fejes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya L.","family":"Heltshe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola J.","family":"Ronan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Joseloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Kappelmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Milan","family":"Macek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida D.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2018.08.013_bb0005","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0010","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.lpm.2017.04.010","article-title":"The diagnosis of cystic fibrosis","volume":"46","author":"De Boeck","year":"2017","journal-title":"Presse Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MCP.0000000000000211","article-title":"The future of CFTR modulating therapies for cystic fibrosis","volume":"21","author":"Davies","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0020","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/cdd.2017.126","article-title":"Strategies for the etiological therapy of cystic fibrosis","volume":"24","author":"Maiuri","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jcf.2018.08.013_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2017.01.002","article-title":"Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2018.08.013_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcf.2016.11.008","article-title":"Biological variability of the sweat chloride in diagnostic sweat tests: a retrospective analysis","volume":"16","author":"Vermeulen","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2018.08.013_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2013.09.007","article-title":"Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data","volume":"13","author":"Accurso","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2018.08.013_bb0040","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1164\/rccm.201603-0459OC","article-title":"Sources of variation in sweat chloride measurements in cystic fibrosis","volume":"194","author":"Collaco","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0045","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/thoraxjnl-2013-204532","article-title":"Sweat chloride is not a useful marker of clinical response to Ivacaftor","volume":"69","author":"Barry","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2018.08.013_bb0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcf.2016.10.009","article-title":"Biomarkers for cystic fibrosis drug development","volume":"15","author":"Muhlebach","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2018.08.013_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.chest.2016.04.006","article-title":"Human epididymis protein 4: a novel serum inflammatory biomarker in cystic fibrosis","volume":"150","author":"Nagy","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2018.08.013_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir. Res."},{"key":"10.1016\/j.jcf.2018.08.013_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-14-38","article-title":"Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies","volume":"14","author":"Clarke","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.jcf.2018.08.013_bb0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2017.09.015","article-title":"CFTR potentiators: from bench to bedside","volume":"34","author":"Jih","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jcf.2018.08.013_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chest.2017.10.005","article-title":"CORK study in CF: sustained improvements in ultra-low dose chest CT scores post CFTR modulation with ivacaftor","volume":"153","author":"Ronan","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2018.08.013_bb0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/rcr2.27","article-title":"Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation","volume":"1","author":"Wood","year":"2013","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.jcf.2018.08.013_bb0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/acb.2011.011258","article-title":"Elevated human epididymis protein 4 concentrations in chronic kidney disease","volume":"49","author":"Nagy","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.jcf.2018.08.013_bb0095","doi-asserted-by":"crossref","DOI":"10.4172\/2161-105X.1000375","article-title":"C-reactive protein in stable cystic fibrosis: an additional indicator of clinical disease activity and risk of future pulmonary exacerbations","volume":"6","author":"Matouk","year":"2016","journal-title":"J. Pulm. Respir. Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0105","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"De Boeck","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2018.08.013_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1258\/0004563021901711","article-title":"Biological variation in sweat sodium chloride conductivity","volume":"39","author":"van der Merwe","year":"2002","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.jcf.2018.08.013_bb0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcf.2016.02.015","article-title":"Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations","volume":"16","author":"Vermeulen","year":"2017","journal-title":"J. Cyst. Fibros."},{"issue":"56","key":"10.1016\/j.jcf.2018.08.013_bb0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1515\/cclm-2017-0530","article-title":"Laboratory performance of sweat conductivity for the screening of cystic fibrosis","volume":"28","author":"Greaves","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0125","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2013.03.004","article-title":"The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation","volume":"12","author":"Seliger","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2018.08.013_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jcf.2016.10.002","article-title":"Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor","volume":"16","author":"Fidler","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.jcf.2018.08.013_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089341","article-title":"Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis","volume":"9","author":"Quon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2018.08.013_bb0140","first-page":"1","article-title":"Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"6","author":"Bergin","year":"2013","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jcf.2018.08.013_bb0145","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jpeds.2008.04.067","article-title":"Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals","volume":"153","author":"Mishra","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jcf.2018.08.013_bb0150","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1164\/rccm.201507-1271LE","article-title":"Intestinal current measurements detect activation of mutant CFTR in patients with cystic fibrosis with the G551D mutation treated with ivacaftor","volume":"192","author":"Graeber","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jcf.2018.08.013_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2478\/jomb-2014-0055","article-title":"Molecular analysis of cystic fibrosis patients in Hungary - an update to the mutational spectrum","volume":"34","author":"Iv\u00e1dy","year":"2015","journal-title":"J. Med. Biochem."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318307951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318307951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:40:12Z","timestamp":1761601212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318307951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1569199318307951"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.08.013","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}